ST LOUIS, May 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that the Niobe magnetic navigation system will be the subject of over 14 separate scientific presentations at Heart Rhythm 2007, the Heart Rhythm Society's 28th Annual Scientific Sessions at the Denver Convention in Denver, Colorado from Wednesday, May 9th through Saturday, May 12th. The Heart Rhythm Society is the preeminent professional group representing physicians and allied specialties of cardiac pacing and cardiac electrophysiology throughout the world. Stereotaxis' clinical utilization and value in all aspects of cardiac electrophysiology will be featured in sponsored symposiums, oral abstracts, and poster presentations, as well as a live use of the system to facilitate cardiac resynchronization therapy. In addition to the main scientific program, Stereotaxis will demonstrate the unique clinical capabilities of magnetic navigation within a fully functioning mobile magnetic EP lab and exhibit booth (108 & 215), a technological first at this important international meeting. In this mobile EP lab, Stereotaxis will unveil its Odyssey(TM) Network Solution. The Odyssey(TM) system has the potential to revolutionize the practice of electrophysiology via comprehensive data integration, real-time customer support worldwide, networked education and training, and the potential for remote viewing and consultation to enhance the quality of patient procedures. Finally, Stereotaxis has also provided an unrestricted educational grant co-sponsoring an educational symposium focused on the "New Era for Complex Ablation" on Wednesday, May 9th at the Adam's Mark Hotel. This meeting will feature leading physicians and institutions in the field of complex ablation and is expected to attract over 900 physicians and associated professionals. The meeting is hosted by the North American Center for Continuing Education.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S. and Europe.

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.

    Contacts:

    Stereotaxis, Inc.
    314-678-6105
    Jim Stolze, Chief Financial Officer
    jstolze@stereotaxis.com

    Russo Partners, LLC
    212-845-4242
    Ben Carmichael (Media)
    benjamin.carmichael@russopartnersllc.com

    Russo Partners, LLC
    212-845-4235
    Matthew Haines (Investors)
    matthew.haines@russopartnersllc.com

SOURCE  Stereotaxis, Inc.
    -0-                             05/08/2007
    /CONTACT:  Jim Stolze, Chief Financial Officer of Stereotaxis, Inc.,
+1-314-678-6105, jstolze@stereotaxis.com; or Media, Ben Carmichael,
+1-212-845-4242, benjamin.carmichael@russopartnersllc.com, or Investors,
Matthew Haines, +1-212-845-4235, matthew.haines@russopartnersllc.com, both of
Russo Partners, LLC, for Stereotaxis, Inc./
    CO:  Stereotaxis, Inc.; Heart Rhythm 2007 Scientific Sessions
ST:  Missouri, Colorado
IN:  HEA MTC
SU:  TDS

FB-FB
-- NYTU154 --
3467 05/08/2007 13:39 EDT http://www.prnewswire.com